Hiromichi Ebi
- Molecular Biology top 5%
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Cancer Research top 2%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Jeffrey A. EngelmanCyril H. BenesSeiji YanoRyan B. CorcoranMari Mino–KenudsonPatricia Della PelleJeffrey SettlemanAnthony C. Faber
- Topics
- Colorectal Cancer Treatments and Studies (29 papers)Lung Cancer Treatments and Mutations (27 papers)Cancer Genomics and Diagnostics (16 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hiromichi Ebi
84 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Molecular Biology 2.5k
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 1.3k
- Cancer Research 1.0k
- Pathology and Forensic Medicine 662
Countries citing papers authored by Hiromichi Ebi
This map shows the geographic impact of Hiromichi Ebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromichi Ebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromichi Ebi more than expected).
Fields of papers citing papers by Hiromichi Ebi
This network shows the impact of papers produced by Hiromichi Ebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromichi Ebi. The network helps show where Hiromichi Ebi may publish in the future.
Co-authorship network of co-authors of Hiromichi Ebi
This figure shows the co-authorship network connecting the top 25 collaborators of Hiromichi Ebi. A scholar is included among the top collaborators of Hiromichi Ebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromichi Ebi. Hiromichi Ebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 40 | |
| 6 | 5 | |
| 7 | 6 | |
| 8 | 92 | |
| 9 | 146 | |
| 10 | 85 | |
| 11 | 108 | |
| 12 | 11 | |
| 13 | 136 | |
| 14 | 174 | |
| 15 | EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenibbreakdown → | 767 |
| 16 | 88 | |
| 17 | 153 | |
| 18 | 31 | |
| 19 | 108 | |
| 20 | Phase I and pharmacokinetic study of weekly docetaxel (DOC) plus irinotecan (IRN) in patients with advanced solid tumors | 1 |
About Hiromichi Ebi
Hiromichi Ebi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 87 papers that have together received 4.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (29 papers), Lung Cancer Treatments and Mutations (27 papers) and Cancer Genomics and Diagnostics (16 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (1.0k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Hiromichi Ebi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Jeffrey A. Engelman, Cyril H. Benes, Seiji Yano, Ryan B. Corcoran, Mari Mino–Kenudson, Patricia Della Pelle, Jeffrey Settleman, Anthony C. Faber, Eugene Lifshits and Kenneth E. Hung. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.